UnknownNot Applicable

Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists

United States200 participantsStarted 2019-09-17

Plain-language summary

The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Ability to provide written informed consent;
✓. At least 18 years of age, male or female;
✓. Prior cataract surgery;
✓. Diagnosed with posterior capsule opacification obstructing vision;
✓. Best-corrected visual acuity less than 20/40 or visual acuity with glare that reduces by 2 lines or more on an ETDRS visual acuity chart or significant effect on activities of daily living

Exclusion criteria

✕. History of underlying ocular disease (not including mild/moderate non-proliferative diabetic retinopathy or incidental findings)
✕. Previous myopic refractive error greater than 6.00 diopters
✕. Complications following previous ocular procedures (i.e. intraocular lens decentration)
✕. Ocular surgery other than uncomplicated cataract or uncomplicated refractive surgery

What they're measuring

Central Visual Acuity

Timeframe: 3 months

Trial details

NCT IDNCT04027595

SponsorNortheastern State University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-22

View on ClinicalTrials.gov More Posterior Capsule Opacification Obscuring Vision trials